Cargando…

E3 ubiquitin ligases and their control of T cell autoreactivity

A loss of T cell tolerance underlies the development of most autoimmune diseases. The design of therapeutic strategies to reinstitute immune tolerance, however, is hampered by uncertainty regarding the molecular mechanisms involved in the inactivation of potentially autoreactive T cells. Recently, E...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonnevier, Jody L, Zhang, Ruan, Mueller, Daniel L
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1297590/
https://www.ncbi.nlm.nih.gov/pubmed/16277698
http://dx.doi.org/10.1186/ar1842
_version_ 1782126225822580736
author Bonnevier, Jody L
Zhang, Ruan
Mueller, Daniel L
author_facet Bonnevier, Jody L
Zhang, Ruan
Mueller, Daniel L
author_sort Bonnevier, Jody L
collection PubMed
description A loss of T cell tolerance underlies the development of most autoimmune diseases. The design of therapeutic strategies to reinstitute immune tolerance, however, is hampered by uncertainty regarding the molecular mechanisms involved in the inactivation of potentially autoreactive T cells. Recently, E3 ubiquitin ligases have been shown to mediate the development of a durable state of unresponsiveness in T cells called clonal anergy. In this review, we will discuss the mechanisms used by E3 ligases to control the activation of T cells and prevent the development of autoimmunity.
format Text
id pubmed-1297590
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-12975902005-12-01 E3 ubiquitin ligases and their control of T cell autoreactivity Bonnevier, Jody L Zhang, Ruan Mueller, Daniel L Arthritis Res Ther Review A loss of T cell tolerance underlies the development of most autoimmune diseases. The design of therapeutic strategies to reinstitute immune tolerance, however, is hampered by uncertainty regarding the molecular mechanisms involved in the inactivation of potentially autoreactive T cells. Recently, E3 ubiquitin ligases have been shown to mediate the development of a durable state of unresponsiveness in T cells called clonal anergy. In this review, we will discuss the mechanisms used by E3 ligases to control the activation of T cells and prevent the development of autoimmunity. BioMed Central 2005 2005-10-12 /pmc/articles/PMC1297590/ /pubmed/16277698 http://dx.doi.org/10.1186/ar1842 Text en Copyright © 2005 BioMed Central Ltd
spellingShingle Review
Bonnevier, Jody L
Zhang, Ruan
Mueller, Daniel L
E3 ubiquitin ligases and their control of T cell autoreactivity
title E3 ubiquitin ligases and their control of T cell autoreactivity
title_full E3 ubiquitin ligases and their control of T cell autoreactivity
title_fullStr E3 ubiquitin ligases and their control of T cell autoreactivity
title_full_unstemmed E3 ubiquitin ligases and their control of T cell autoreactivity
title_short E3 ubiquitin ligases and their control of T cell autoreactivity
title_sort e3 ubiquitin ligases and their control of t cell autoreactivity
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1297590/
https://www.ncbi.nlm.nih.gov/pubmed/16277698
http://dx.doi.org/10.1186/ar1842
work_keys_str_mv AT bonnevierjodyl e3ubiquitinligasesandtheircontroloftcellautoreactivity
AT zhangruan e3ubiquitinligasesandtheircontroloftcellautoreactivity
AT muellerdaniell e3ubiquitinligasesandtheircontroloftcellautoreactivity